30 Years of Evidence
Featured Content
pancreatic cancer awareness
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
pancreatic cancer awareness
Long-Term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-Metastatic Pancreatic Cancer
pancreatic cancer awareness
Use of Nab-Paclitaxel Plus Gemcitabine Followed by Hypofractionated Tomotherapy With Simultaneous Integrated Boost in Patients With Locally Advanced Pancreatic Cancer
Stereotactic Radiosurgery for Sarcoma Metastases to the Brain: A Single-institution Experience
Zamarud A, Park DJ, Dadey DYA, Yoo KH, Marianayagam NJ, Yener U, Szalkowski GA, Pollom E, Soltys S, Chang SD, Meola A. | Neurosurg Focus. | 2023
Lung-heart Toxicity in a Randomized Clinical Trial of Hypofractionated Image Guided Radiation Therapy for Breast Cancer
Van Parijs H, Cecilia-Joseph E, Gorobets O, Storme G, Adriaenssens N, Heyndrickx B, Verschraegen C, Nguyen NP, De Ridder M, Vinh-Hung V | Front Oncol. | 2025
Toxicity of Dose-escalated, Hypofractionated Helical TomoTherapy for Inoperable Thoracic Esophageal Squamous Cell Carcinoma
Zhang SM, Sun J, Pan XO, Zhu WC, Zhou YK | World J Clin Oncol | 2025
Long-term Cardiac Outcomes in Breast Cancer Patients Treated with Helical TomoTherapy: Evaluating the Applicability of 3D-based Dose Constraints for Intensity Modulated Radiation Therapy
Loap P, Uakkas A, Bouziane J, Fourquet A, Kirova Y | Int J Cancer | 2025
Automated Deep Inspiration Breath-Hold (DIBH) in Breast Radiotherapy: A Comprehensive Assessment of the VitalHold System on the Radixact Platform
Retif P, Djibo Sidikou A, Gribelbauer J, Al Salah A, Pfletschinger E, Michel X | Phys Med | 2025
A Dosimetric Comparison of Helical TomoTherapy Treatment Delivery with Real-time Adaption and No Motion Correction
Hindmarsh J, Crowe S, Johnson J, Sengupta C, Walsh J, Dieterich S, Booth J, Keall P | Phys Imaging Radiat Oncol | 2025
Plan Quality Comparison at Five Years in Two Cohorts of Breast Cancer Patients Treated with Helical TomoTherapy
Dicuonzo S, Zerella MA, Zaffaroni M, Vincini MG, Amin K, Ronci G, D’arcangelo M, Rojas DP, Morra A, Gerardi MA, Fodor C, Cambria R, Luraschi R, Cattani F, Veronesi P, De Lorenzi F, Rietjens M, Orecchia R, Leonardi MC, Jereczek-Fossa BA | J Clin Med | 2025
Long-term Outcomes of Salvage Radiotherapy Using TomoTherapy With Image-guided Radiotherapy for Postoperative Prostate Cancer Patients
Mukai Y, Omura M, Minagawa Y, Mase M, Nishikawa Y, Miura I, Hata M | Cancer Diagn Progn | 2025
Long-Term Results of Intensity Modulated Radiotherapy (IMRT) with Helical Tomotherapy in Non-Metastatic Breast Cancer Patients: Final Analysis
Loap P, Uakkas A, Allali S, Bouziane J, Fourquet A, Kirova Y | Cancers (Basel) | 2025
Rationale, Implementation Considerations, Delineation and Planning Target Objective Recommendations for Volumetric Modulated Arc Therapy and Helical TomoTherapy Total Body Irradiation, Total Marrow Irradiation, Total Marrow and Lymphoid Irradiation and Total Lymphoid Irradiation
Hoeben BAW, Saldi S, Aristei C, Engellau J, Ocanto A, Hiniker SM, Misson-Yates S, Kobyzeva DA, Pazos M, George Mikhaeel N, Rodriguez-Roldan M, Seravalli E, Bosman ME, Han C, Losert C, Engström PE, Fulcheri CPL, Zucchetti C, Ferrer C, Hussein M, Loginova AA, Clark CH, Wong JYC | Radiother Oncol | 2025
Prognostic Analysis of Helical TomoTherapy Stereotactic Body Radiotherapy in Multiple Primary or Second Primary Lung Cancers
Ma J, Xu X, Huang W, Hu Y, Chen G, He J | BMC Cancer | 2025
Verification of Daily Dose Recalculation Accuracy for an Adaptive Radiation Therapy Monitoring Tool in Helical TomoTherapy for Nasopharyngeal Carcinoma
Maneepan Y, Watcharawipha A, Chitapanarux I, Wanwilairat S, Nobnop W | J Appl Clin Med Phys | 2024
Impact of Ground-glass Component on Prognosis in Early-stage Lung Cancer Treated with Stereotactic Body Radiotherapy Via Helical TomoTherapy
Ma J, Fan S, Huang W, Xu X, Hu Y, He J | Radiat Oncol | 2024
Risk Factors for Treatment-related Sensorineural Hearing Loss and Hearing Aid use in Medulloblastoma Patients: An Observational Cohort Study
Troschel FM, Steike DR, Roers J, Kittel C, Siats J, Parfitt R, Hesping AE, Am Zehnhoff-Dinnesen A, Neumann K, Eich HT, Scobioala S | Strahlenther Onkol | 2024
Improved Quality of Life in Head and Neck Cancer Patients Treated with Modern Arc Radiotherapy Techniques – A Prospective Longitudinal Analysis
Chuang EY, Hou PY, Shueng PW, Lo WC, Lin PY, Lin SC, Wu PH, Jiang JG, Chung CS, Hsu CX, Kuo DY, Lu YF, Liao LJ, Hsieh CH | Front Oncol | 2024
Ablative Radiotherapy for Inoperable Non-Metastatic Pancreatic Cancer: Long-Term Results in a Single Center
Jing Wang et al. | ASTRO | 2025
Reirradiation with SBRT in Radiorecurrent Prostate Cancer: Impact on Disease Control and Quality of Life Outcomes
Papaiah Sridhar et al. | ASTRO | 2025
PSMA Based Dose Escalation to Dominant Intraprostatic Lesion (DIL) in Localized Carcinoma Prostate Treated with Stereotactic Body Radiotherapy
Papaiah Susheela Sridhar et al. | ASTRO | 2025
Optimizing PTV Generation and Comparison of OAR Dosimetry with Different Rectal Spacers in Patients Treated with HDR-Like Prostate SBRT
Emily Hollis et al. | ASTRO | 2025
To Space or Not to Space: The EPIC question for Prostate Stereotactic Radiation (SBRT) with or without Hydrogel Rectal Spacer (RS)
Madeline Flanagan et al. | ASTRO | 2025
